SWOG clinical trial number
SWOG-7424/7425
Combination Chemotherapy Utilizing BCNU Hydroxyurea and DTIC (BHD) with and without BCG and DTIC with BCG in the Treatment of Patients with Disseminated Malignant Melanoma.
Closed
Abbreviated Title
Combination Chemotherapy Utilizing BCNU Hydroxyurea and DTIC (BHD) with and without BCG and DTIC with BCG in the Treatment of Patients with Disseminated Malignant Melanoma.
Activated
10/08/1974
Closed
01/01/1977
Publication Information Expand/Collapse
1982
Combination chemotherapy pluc BCG in the treatment of disseminated malignant melanoma: A Southwest Oncology Group study.
1980
Chemoimmunotherapy for disseminated melanoma (DM)a
1979
Chemoimmunotherapy for disseminated melanoma.
1978
Chemotherapy and BCG in treatment of disseminated malignant melanoma.
Value of cellular mediating immunity in patients with disseminated melanoma treated with chemoimmuno- therapy.
Prognostic value of pre-therapy total peripheral lymphocites and white blood cells in patients with advanced malignant melanoma.
1977
Chemotherapy and BCG in the treatment of disseminated melanoma: A Southwest Oncology Group study.
1976
Combination chemoimmunotherapy for disseminated malignant melanoma (DMM).